Chemoinformaics analysis of 5-TETRADECEN-14-OLIDE
| Molecular Weight | 224.344 | nRot | 0 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 16 |
| Exact Molecular Weight | 224.178 | nRing | 1 |
| Solubility: LogS | -5.006 | nHRing | 1 |
| Solubility: LogP | 5.033 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 40.987 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.459 |
| Synth | 2.795 |
| Natural Product Likeliness | 0.826 |
| NR-PPAR-gamma | 0.38 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.016 |
| Pgp-sub | 0.026 |
| HIA | 0.004 |
| CACO-2 | -4.66 |
| MDCK | 0.0000297 |
| BBB | 0.362 |
| PPB | 0.960125 |
| VDSS | 1.068 |
| FU | 0.041417 |
| CYP1A2-inh | 0.973 |
| CYP1A2-sub | 0.182 |
| CYP2c19-inh | 0.745 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.603 |
| CYP2c9-sub | 0.894 |
| CYP2d6-inh | 0.071 |
| CYP2d6-sub | 0.176 |
| CYP3a4-inh | 0.491 |
| CYP3a4-sub | 0.091 |
| CL | 9.589 |
| T12 | 0.528 |
| hERG | 0.172 |
| Ames | 0.009 |
| ROA | 0.027 |
| SkinSen | 0.966 |
| Carcinogencity | 0.512 |
| EI | 0.979 |
| Respiratory | 0.511 |
| NR-Aromatase | 0.171 |
| Antiviral | Yes |
| Prediction | 0.794058 |